Dr. Lal Path Labs · NSE: LALPATHLAB · BSE: 539524
Q1 FY23 results · Apr–Jun 2022
Dr. Lal Path Labs reported revenue from operations of ₹502.70 crore (down 17.1% from Q1 FY22) and net profit of ₹58.20 crore (down 56.5% from Q1 FY22) for Q1 FY23 (Apr–Jun 2022), on a consolidated basis.
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 502.70 | 606.60 | −17.1% | 485.50 | +3.5% |
| Other income | 8.30 | 14.10 | −41.1% | 12.00 | −30.8% |
| Total income | 511.00 | 620.70 | −17.7% | 497.50 | +2.7% |
| Profit before tax | 81.40 | 179.30 | −54.6% | 83.50 | −2.5% |
| Net profit for the period | 58.20 | 133.70 | −56.5% | 62.10 | −6.3% |
| Attributable to shareholders of the company | 57.70 | 131.20 | −56.0% | 61.30 | −5.9% |
| EPS, basic (₹) | 6.97 | 15.87 | −56.1% | 7.41 | −5.9% |
| Net margin (%) | 11.6 | 22.0 | 12.8 |
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 439.30 | 564.90 | −22.2% | 414.90 | +5.9% |
| Other income | 18.80 | 13.50 | +39.3% | 12.90 | +45.7% |
| Total income | 458.10 | 578.40 | −20.8% | 427.80 | +7.1% |
| Profit before tax | 101.70 | 165.20 | −38.4% | 85.10 | +19.5% |
| Net profit for the period | 79.60 | 123.30 | −35.4% | 65.20 | +22.1% |
| EPS, basic (₹) | 9.61 | 14.93 | −35.6% | 7.88 | +22.0% |
| Net margin (%) | 18.1 | 21.8 | 15.7 |
Consolidated
- Filed with BSE
- 29 Jul 2022, 10:29 IST
- Board meeting
- 28 Jul 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 29 Jul 2022, 10:29 IST
- Board meeting
- 28 Jul 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE